Robert Freedland Profile Picture Individual Investor

Robert Freedland

Ophthalmologist,Hospital and Health Care

  • EducationPrinceton University; University of California, Davis
  • QualificationsAB, MD
  • Investment ExperienceManaging own investments for 42 years, active stock blogger/podcaster for 7 years


My portfolio invests in healthcare-related stocks. It attemps to identify companies with reasonable valuations and good prospects for growth including ones that offer possible dividends to stockholders. These companies will range from drug, device, retail sales, electronic medical record, prescription services, and HMO/hospital companies. While emphasizing mid cap stocks, large cap and smaller capitalization companies may be included as well as emerging medical treatments/technologies.

Risk score

Risk Score 3

Best 30 days


Worst 30 days


  • -3.7%
    30 day
  • -0.9%
    90 day
  • 37.5%
    365 day
    October 06, 2010
Monthly vs S&P500
Robert Freedland - Healthcare Monthly vs S&P500
20.6% 12 months
  • $10,000 subscription min
  • 1% fee


  • Replicable

Top 5 Holdings View all


Portfolio commentary

  1. Investing lessons from the biotech rout

    11 April 2014

    This is a month that tested my investment skills.

  2. Biotech stocks look for bounce amid bubble talk 26 March 2014
  3. Healthcare portfolio manager says Obamacare, Boomers driving sector 28 January 2014
  4. Looking back at two years of Sustained Momentum portfolio 18 January 2014
  5. Looking back on almost five years with Covestor 16 January 2014

show more

Performance detail

  • Manager (net of fees)
  • S&P 500 Healthcare


Inception October 06, 2010

as of April 21, 2014 Manager (net of fees) S&P 500 Healthcare S&P 500
Past 30 days -3.7% -1.2% 0.4%
Past 90 days -0.9% 0.8% 2.1%
Past 365 days 37.5% 23.0% 22.9%
Since Inception (Annualized) 19.1% 22.0% 16.9%
2014 (YTD) 7.4% 4.3% 1.9%
2013 49.8% 41.5% 32.4%
2012 18.8% 17.9% 16.0%
2011 -7.4% 12.7% 2.1%

Risk metrics

Last 365 days

as of April 21, 2014 Manager (net of fees) S&P 500 Healthcare S&P 500
Best 30 days 12.7% 9.5% 7.9%
Worst 30 days -8.8% -6.1% -4.8%
Volatility 15.8% 13.5% 11.4%
Sharpe Ratio 2.38 1.70 2.01
Sortino Ratio 3.61 2.41 2.82
Maximum Drawdown -10.7% -7.0% -5.7%
Value-at-risk (95%, 1 week) -3.7% -3.1% -2.6%
vs. S&P 500 Healthcare vs. S&P 500
Information Ratio 1.91 1.44
Alpha 11.1% 10.5%
Beta 1.02 1.06
R-Squared 0.77 0.59
  • $10,000 subscription min
  • 1% fee

Latest transactions View all

Average trades per month 9.6
Executed Symbol Security Replicable Type Price
04/21/14 ACT Actavis plc Yes Buy $203.22
04/17/14 BSX Boston Scientific Corp Yes Buy $13.53
04/17/14 UNH UnitedHealth Group Inc Yes Sell $75.69
04/16/14 SLXP Salix Pharmaceuticals Ltd Yes Buy $99.77
04/15/14 SIRO Sirona Dental Systems Inc Yes Buy $74.60
04/14/14 ABT Abbott Laboratories Yes Buy $37.62
04/11/14 VAR Varian Medical Systems Inc Yes Sell $80.65
04/10/14 AMGN Amgen Inc Yes Sell $115.17

Important Information

  1. Past performance is no guarantee of future results.
  2. Performance of the portfolio manager's account is calculated by Covestor on a daily time-weighted basis, including cash, dividends and earnings distributions, and broker commissions. Manager returns include trades that fail Covestor's trading rules, do not reflect any Covestor suitability or risk score restrictions and are exclusive of Covestor fees. More
  3. Average subscription returns ("Avg Sub" or "Avg Client") are calculated by Covestor and are composed of the average, daily, time weighted returns of all active subscriptions to the underlying portfolio. These daily average returns are then linked together for the timeframe requested. In addition, these returns include cash, dividends and earnings distributions, brokerage commissions, Covestor advisory fees, and reflect individual client suitability and risk score restrictions. More
  4. All graph data is as of the end of day for the referenced period, unless otherwise specified. The subscription minimum is the minimum subscription required to follow a particular portfolio. The minimum amount is determined by Covestor, based on the characteristics of the underlying portfolio. It should not be considered as specific investment advice for your investment situation.
  5. The performance charts are provided for informational purposes only, and should not be used as the basis for making an investment decision. Variables such as corporate actions or foreign exchange may affect daily performance displays. We rely on mathematical formulas, computer programs, and pricing information from third-party vendors to provide these returns. Neither Covestor nor any of its data or content providers shall be liable for any errors in this information or any actions taken by you in reliance upon this information.
  6. Benchmark returns have been calculated by Covestor using a time-weighted calculation of daily index valuations. Benchmarks presented are total return and therefore inclusive of cash, dividends and earnings distributions but not transaction costs. More
  7. Leverage indicates the level of margin utilized and is calculated by dividing gross exposure by portfolio net liquidation value.
  8. All Portfolio Manager information including personal data, profiles, strategies, monthly investment reports, and historical results outside of Covestor has been provided by the Portfolio Manager. Covestor makes no representation or warranty of its accuracy, completeness or relevance and it does not represent the opinions of Covestor. Transaction history is available upon request. Portfolio classifications (Approach, Asset Class) are provided by Covestor, and are intended to serve as a general guide.
  9. These securities are currently held in the portfolio manager's brokerage account. Holdings in the "Replicable Holdings" table currently pass Covestor's trading rules, subject to individual client constraints. Eligibility for replication may change over time. Actual client subscription holdings may vary.
  10. These transactions were executed in the portfolio manager's brokerage account. Those marked as "Replicable Transactions" passed Covestor's trading rules and were eligible for replication at the time of execution, subject to individual client constraints. Eligibility for replication may change over time. Actual client subscription trade activity may vary.
  11. S&P 500 Index is an unmanaged index compiled by Standard & Poor´s Corp. Index returns do not reflect any management fees, transaction costs or expenses. Individuals cannot invest directly in an Index. S&P 500 index data: S&P/Dow Jones Indices LLC, a subsidiary of The McGraw-Hill Companies Copyright © 2014.